UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000021552
Receipt number R000024664
Scientific Title Open, randomized, active-controlled insulin resistance outcome trial of safety and efficacy with empagliflozin in type 2 diabetic patients
Date of disclosure of the study information 2016/03/30
Last modified on 2020/09/23 16:46:34

No. Disposal Last modified on Item of update
1 Insert 2016/03/21 10:29:53
2 Update 2016/04/03 15:24:26 Name of primary person or sponsor
Organization
Category of Funding Organization
3 Update 2016/04/03 15:45:06 Acronym
Acronym
4 Update 2017/03/22 23:32:18 Last follow-up date
5 Update 2017/07/03 22:47:02 Recruitment status
Last follow-up date
6 Update 2018/03/22 12:55:58 Last follow-up date
7 Update 2018/09/21 11:05:36 Last follow-up date
8 Update 2018/10/16 20:36:48 Research ethics review
9 Update 2019/03/23 18:10:44 Date of IRB
10 Update 2019/03/23 18:13:05 Number of participants that the trial has enrolled
11 Update 2019/09/22 09:58:55 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Email2
Email3
Organization
Organization
Address
Address
Tel
Email
12 Update 2020/03/23 10:05:29 Last follow-up date
13 Update 2020/03/24 13:26:09 Email1
Email3
Email
14 Update 2020/09/23 16:44:38 URL releasing protocol
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results
Results date posted
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures
15 Update 2020/09/23 16:45:51 Recruitment status
16 Update 2020/09/23 16:46:34 Publication of results
Participant flow